VitaDAO, a leader in decentralized science (DeSci) focusing on longevity research, has been awarded 21 million BIO tokens through Bio Protocol’s bio/acc rewards program. This significant allocation recognizes VitaDAO’s pioneering contributions to the DeSci ecosystem and longevity research.
BIO Genesis Auction Now Live
BIO Genesis link
The BIO Genesis token generation event is currently underway, offering the first opportunity to acquire BIO tokens before they become transferable in Q4 2024. Key details:
- Four rounds, with Round One allowing swaps of eligible DeSci tokens (including $VITA) for BIO
- Capped at approximately $5 million in total contributed value (depending on DeSci token prices)
- 50% of tokens claimable immediately, 50% vesting linearly over 1 year
Eligible tokens for the BIO Genesis auction: $VITA $NEURON $HAIR $GROW $ATH $CRYO $PSY $RSC
VitaDAO’s Opportunities in “Science Finance” (SciFi)
As a BIO token holder, VitaDAO can now participate in governing core operations of the BIO Protocol:
1. Curation: Vote on bioDAOs joining the ecosystem
2. Funding: Engage with BIO’s auction contracts for bioDAO fundraising
3. Liquidity: Participate in onchain liquidity provision
4. Bio/acc Rewards: Direct incentives for bioDAOs that reach key milestones
5. Meta-Governance: Govern a range of bioDAOs and scientific IP assets
These governance rights position VitaDAO to play a pivotal role in shaping the future of DeSci and the broader biotech landscape.
Impact on DeSci and Longevity Research
The Bio Protocol aims to create an open financial network for programmable biology, making decentralized science more liquid and accessible. VitaDAO’s involvement signifies a new era in DeSci, potentially accelerating breakthroughs in longevity research.
As a key player in this ecosystem, VitaDAO is well-positioned to:
- Drive innovation in longevity research
- Create value for VITA token holders
- Contribute significantly to the broader DeSci community’s progress
The BIO token serves as a gateway to DeSci, putting VitaDAO at the forefront of this revolutionary approach to scientific funding and development in longevity research.
